Eszopiclone API Market, Global Outlook and Forecast 2023-2030
Eszopiclone is a nonbenzodiazepine, cyclopyrrolone and active stereoisomer of?zopiclone?with hypnotic and sedative activity and without significant anxiolytic activity. Although the exact mechanism of action remains to be fully elucidated, eszopiclone is able to bind to and activate the omega-1 subtype of the alpha subunit of the?gamma-aminobutyric acid-benzodiazepine?GABA?receptor complex (GABA-A), a?chloride?ionophore complex in the central nervous system (CNS). This leads to the opening of?chloride?channels, causing hyperpolarization, inhibition of neuronal firing, and enhancement of the inhibitory effect of?GABA. This eventually leads to a hypnotic effect and allows for an induction of sleep.
This report aims to provide a comprehensive presentation of the global market for Eszopiclone API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Eszopiclone API. This report contains market size and forecasts of Eszopiclone API in global, including the following market information:
Global Eszopiclone API Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Eszopiclone API Market Sales, 2018-2023, 2024-2030, (Ton)
Global top five Eszopiclone API companies in 2022 (%)
The global Eszopiclone API market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Purity?98% Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Eszopiclone API include Dr. Reddy?s Laboratories Ltd., Farmak A.S, Teva API, Symed Labs Limited, Glenmark Pharmaceuticals, Centaur Pharmaceuticals and Orchid Chemicals & Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Eszopiclone API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Eszopiclone API Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (Ton)
Global Eszopiclone API Market Segment Percentages, by Type, 2022 (%)
Purity?98%
Purity<98%
Global Eszopiclone API Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (Ton)
Global Eszopiclone API Market Segment Percentages, by Application, 2022 (%)
Eszopiclone Tablets
Others
Global Eszopiclone API Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (Ton)
Global Eszopiclone API Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Eszopiclone API revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Eszopiclone API revenues share in global market, 2022 (%)
Key companies Eszopiclone API sales in global market, 2018-2023 (Estimated), (Ton)
Key companies Eszopiclone API sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Dr. Reddy?s Laboratories Ltd.
Farmak A.S
Teva API
Symed Labs Limited
Glenmark Pharmaceuticals
Centaur Pharmaceuticals
Orchid Chemicals & Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Eszopiclone API, market overview.
Chapter 2: Global Eszopiclone API market size in revenue and volume.
Chapter 3: Detailed analysis of Eszopiclone API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Eszopiclone API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Eszopiclone API capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
